Literature DB >> 22367666

A phenotype map for 14q32.3 terminal deletions.

Hartmut Engels1, Herdit M Schüler, Alexander M Zink, Eva Wohlleber, Antje Brockschmidt, Alexander Hoischen, Matthias Drechsler, Jennifer A Lee, Kerstin U Ludwig, Christian Kubisch, Gesa Schwanitz, Ruthild G Weber, Barbara Leube, Raoul C M Hennekam, Sabine Rudnik-Schöneborn, Martina Kreiss-Nachtsheim, Heiko Reutter.   

Abstract

Detailed molecular-cytogenetic studies combined with thorough clinical characterization are needed to establish genotype-phenotype correlations for specific chromosome deletion syndromes. Although many patients with subtelomeric deletions have been reported, the phenotype maps for many of the corresponding syndromes, including the terminal deletion 14q syndrome, are only slowly emerging. Here, we report on five patients with terminal partial monosomy of 14q32.3 and characteristic features of terminal deletion 14q syndrome. Four of the patients carry de novo terminal deletions of 14q, three of which have not yet been reported. One patient carries an unbalanced translocation der(14)t(9;14)(q34.3;q32.3). Minimum deletion sizes as determined by molecular karyotyping and FISH are 5.82, 5.56, 4.17, 3.54, and 3.29 Mb, respectively. Based on our findings and a comprehensive review of the literature, we refine the phenotype map for typical clinical findings of the terminal deletion 14q syndrome (i.e., intellectual disability/developmental delay, muscular hypotonia, postnatal growth retardation, microcephaly, congenital heart defects, genitourinary malformations, ocular coloboma, and several dysmorphic signs). Combining this phenotype map with benign copy-number variation data available from the Database of Genomic Variants, we propose a small region critical for certain features of the terminal deletion 14q syndrome which contains only seven RefSeq genes.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22367666     DOI: 10.1002/ajmg.a.35256

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  Chromosomal Microarray Analysis in Children with Unexplained Developmental Delay/Intellectual Disability.

Authors:  Pinar Arican; Nihal Olgac Dundar; Berk Ozyilmaz; Dilek Cavusoglu; Pinar Gencpinar; Kadri Murat Erdogan; Merve Saka Guvenc
Journal:  J Pediatr Genet       Date:  2018-12-14

2.  Major Contribution of Genomic Copy Number Variation in Syndromic Congenital Heart Disease: The Use of MLPA as the First Genetic Test.

Authors:  Rejane A C Monteiro; Mariana L de Freitas; Gabrielle S Vianna; Valdirene T de Oliveira; Rafaella X Pietra; Luana C A Ferreira; Patrícia P O Rocha; Michele da S Gonçalves; Giovana da C César; Joziele de S Lima; Paula F V Medeiros; Juliana F Mazzeu; Fernanda S Jehee
Journal:  Mol Syndromol       Date:  2017-06-14

3.  Endocrinological features of a patient with 14q microdeletion and Dubowitz phenotype.

Authors:  Maria Elisa Amodeo; Elena Inzaghi; Annalisa Deodati; Stefano Cianfarani
Journal:  Mol Genet Genomic Med       Date:  2021-03-31       Impact factor: 2.183

Review 4.  New microdeletion and microduplication syndromes: A comprehensive review.

Authors:  Julián Nevado; Rafaella Mergener; María Palomares-Bralo; Karen Regina Souza; Elena Vallespín; Rocío Mena; Víctor Martínez-Glez; María Ángeles Mori; Fernando Santos; Sixto García-Miñaur; Fé García-Santiago; Elena Mansilla; Luis Fernández; María Luisa de Torres; Mariluce Riegel; Pablo Lapunzina
Journal:  Genet Mol Biol       Date:  2014-03       Impact factor: 1.771

5.  Transcriptomics unravels molecular players shaping dorsal lip hypertrophy in the vacuum cleaner cichlid, Gnathochromis permaxillaris.

Authors:  Laurène Alicia Lecaudey; Pooja Singh; Christian Sturmbauer; Anna Duenser; Wolfgang Gessl; Ehsan Pashay Ahi
Journal:  BMC Genomics       Date:  2021-07-05       Impact factor: 3.969

6.  Chromosome duplication (14q) and the genotype phenotype correlation.

Authors:  Ariane Sadr-Nabavi; Morteza Saeidi
Journal:  Int J Fertil Steril       Date:  2014-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.